Skip to content
Government Federal, Medical Health Aged Care

Media alert – Uluru Statement signatory Thomas Mayo; PHAA President to speak 10am today on health community’s support for Voice proposal

Public Health Association of Australia 2 mins read

The Public Health Association of Australia (PHAA) and Yes23 invite the Tasmanian media today to meet Thomas Mayo, a signatory to the Uluru Statement from the Heart and national Yes Campaign spokesperson, and PHAA President, Adj Prof Tarun Weeramanthri AM.

Mayo will be attending the Australian Public Health Conference at Hotel Grand Chancellor, Hobart, a gathering of more than 450 experts including public health practitioners, policymakers, researchers, academics, and students.

Mayo and Adj Prof Weeramanthri will discuss the health community’s support for the Voice to Parliament. More than 125 health and medical organisations, including the PHAA, issued on open letter on Monday about why they endorse and Aboriginal and Torres Strait Islander Voice to Parliament.

WHAT: Thomas Mayo in Hobart

WHERE: Australian Public Health Conference at Hotel Grand Chancellor, Hobart (Mezzanine level)

WHEN: 10am, Wednesday, September 27

Special Note: Thomas Mayo, Adj Prof Tarun Weeramanthri AM, President of the Public Health Association of Australia, and Jamie Currie, the CEO of SETAC (South East Tasmania Aboriginal Corporation) will be available for media interview.

Mayo is a Kaurareg Aboriginal and Kalkalgal, Erubamle Torres Strait Islander man. He is also the Assistant National Secretary of the MUA.

As a signatory of the Uluru Statement from the Heart, Mayo has been a leading advocate since its inception in May 2017. He is the Chairperson of the Northern Territory Indigenous Labor Network and a director on the Australians for Indigenous Constitutional Recognition board.

The PHAA is Australia’s peak body for public health and represents more than 2,000 people across the continent. It has long supported the Uluru Statement from the Heart and Voice to Parliament proposal.

Media contacts: (Thomas Mayo) A.Mark Thomas, M&M Communications, 0422 006 732

(PHAA President) Paris Lord, PHAA Communications Manager, 0478 587 917, [email protected]

 


Contact details:

Media contacts: (Thomas Mayo) A.Mark Thomas, M&M Communications, 0422 006 732

(PHAA President) Paris Lord, PHAA Communications Manager, 0478 587 917, [email protected]

Media

More from this category

  • Government Federal, Mental Health
  • 17/12/2025
  • 17:05
Australians for Mental Health

Australians for Mental Health welcomes mental health spend in mid-year budget update

Australians for Mental Health welcomes mental health spend in mid-year budget update Australians for Mental Health has welcomed the federal government’s decision to fund its election commitment of more than $1 billion for mental health care. The Mid-Year Economic and Fiscal Outlook released today confirms the mental health funding boosts, which will expand services and provide a boost to the workforce. The funding includes $500 million spent on a new network for 20 Youth Specialist Care Centres, $267.3 million for 32 new and upgraded Medicare Mental Health Centres, $225.3 million for 58 new, upgraded or expanded Headspace services and $83.9…

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.